India Today shows that certain sources have told India Today that the govt has approved Russia's Sputnik V COVID-19 vaccine for emergency use in India, based on its strong immunogenicity data.
Sputnik V is a viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology. Registered on 11 August 2020 by the Russian Ministry of Health as Gam-COVID-Vac, Sputnik V is an adenovirus viral vector vaccine. The "V" in the name is the letter V, not the Roman numeral for five.
Gam-COVID-Vac was initially approved for distribution in Russia on the preliminary results of Phase I-II studies eventually published on 4 September 2020. The quick approval in early August of Gam-COVID-Vac was certainly met with criticism in mass media and precipitated discussions in the scientific community whether this decision was justified in the absence of robust scientific research confirming the safety and efficacy of the vaccine. On 2 February 2021, an interim analysis from the trial was published in The Lancet, indicating 91.6% efficacy without unusual side effects.
No comments:
Post a Comment